Mad Money Uncovered...
Health Care: Drugs
Synthetic Biologics Inc (SYN: AMEX)
$1.44 0.02 | 1.41%
05/20/13 - 03:58 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -17.07M | -7.63M | -1.71M | -3.73M |
| Operating Gains/Losses | -677.00K | -37.00K | -3.24K | 34.40K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 14.00K | -480.00K | -438.34K | -48.29K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 518.00K | -334.45K | 0.00 |
| (Decrease) Increase In Payables | 7.00K | 153.00K | -195.42K | -138.26K |
| (Decrease) Increase In Other Current Liabilities | -29.00K | -205.00K | 201.86K | -28.44K |
| (Increase) Decrease In Other Working Capital | -6.00K | 60.00K | 0.00 | -78.86K |
| Other Non-Cash Items | 11.32M | 4.54M | 982.14K | 628.35K |
| Net Cash From Continuing Operations | -8.92M | -2.88M | -1.14M | -2.92M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -8.92M | -2.88M | -1.14M | -2.92M |
| Sale of Property, Plant & Equipment | 0.00 | 2.00K | 77.26K | 25.20K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 4.29M | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -10.00K | 0.00 | -12.66K | -1.85K |
| Acquisitions | 0.00 | 0.00 | 0.00 | -195.52K |
| Purchases of Short-Term Investments | 0.00 | -4.37M | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -10.00K | -75.00K | 64.60K | -172.17K |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 12.20M | 7.52M | 1.13M | 10.73K |
| Repayment of Long-Term Debt | 0.00 | 0.00 | -5.39K | -11.34K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | -49.71K |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -539.00K | -115.28K | -1.00 |
| Net Cash From Financing Activities | 12.20M | 6.98M | 1.01M | -50.31K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 3.28M | 4.03M | -66.19K | -3.14M |
Portfolios with SYN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest SYN Headlines from TheStreet
- 3 Biotech Stocks Under $5 Moving Higher 02.07.13 | 02:02 pm
- 5 Stocks Poised for Breakouts 07.13.12 | 12:07 pm
- Synovus To Raise $350M in Stock Offer 09.14.09 | 11:09 pm
- Regions' Profit Stung by Fla. Real Estate 07.22.08 | 11:07 am
- Stock Upgrades, Downgrades from TheStreet.com Ratings 11.21.07 | 01:11 pm
- Cramer's 'Mad Money Lightning Round': Best BuyBuyBuy 10.01.07 | 07:10 pm
- Neurocrine Says Sleeping Pill Data Are Good 11.14.02 | 09:11 am
Press Releases for SYN
- Synthetic Biologics Announces Issuance Of U.S. Patent Covering Combination Of Estriol And Copaxone® For Multiple Sclerosis - PR Newswire 04.04.13 | 01:04 pm
- Synthetic Biologics To Present At The 25th Annual ROTH Conference - PR Newswire 03.12.13 | 07:03 am
- Infectious Disease Specialist, Brad Spellberg, M.D., Joins Synthetic Biologics' Scientific Advisory Board - PR Newswire 02.26.13 | 07:02 am
- Synthetic Biologics Reports That Flupirtine Sublicensee, Meda AB, To Initiate Phase II Fibromyalgia Clinical Trial In U.S. - PR Newswire 02.22.13 | 07:02 am
- Synthetic Biologics To Present At The 2013 BIO CEO & Investor Conference - PR Newswire 02.05.13 | 07:02 am
- Synthetic Biologics To Present At OneMedForum San Francisco 2013 - PR Newswire 01.07.13 | 07:01 am
- Synthetic Biologics And Intrexon Corporation Initiate Development Of Monoclonal Antibodies For Whooping Cough (Pertussis) - PR Newswire 12.20.12 | 04:12 pm
- Synthetic Biologics Closes Deal For Acquisition Of C. Difficile Infectious Disease Program - PR Newswire 12.03.12 | 02:12 pm
- Synthetic Biologics To Present At The Fifth Annual LD MICRO Conference In Los Angeles - PR Newswire 11.30.12 | 01:11 pm
- Synthetic Biologics To Acquire Clinical-Stage C. Difficile Infectious Disease Program - PR Newswire 11.12.12 | 07:11 am
Partner Headlines for SYN
